Hearing aids are now available over the counter from Walgreens, CVS and Best Buy

Hearing aids are now available over the counter from Walgreens, CVS and Best Buy


Jennifer Nealon, Marketing Director at Hear Again America, holds hearing aids that they sell on October 19, 2021 in Boca Raton, Florida.

Joe Raedle | Getty Images

Millions of Americans with hearing loss can now purchase hearing aids without a prescription or medical exam from Walgreens, CVS and Best Buy , according to the companies.

Walgreens on Monday started selling over-the-counter hearing aids online and at its stores nationwide for $799 a pair. By comparison, the average cost of prescription hearing aids can range between $2,000 and $8,000, according to the company.

CVS is selling over-the-counter devices on its website with prices ranging from $199 to $999. The drug store chain will start also offering them at select pharmacy locations beginning in November.

Best Buy is offering 20 different over-the-counter hearing aids online with prices ranging from $200 to $3,000, according to the company. The electronics retailer will offer the devices in 300 stores across the country later this month.

And Hy-Vee, a supermarket chain, will offer four different hearing aids online and in 34 locations across Iowa, Kansas, Minnesota, Missouri, Nebraska and Wisconsin this week. Prices range from $499 to $999. By the end of the year, the devices will be available in 100 stores.

The Food and Drug Administration issued a rule in August that allowed over-the-counter sales of hearing aids for adults ages 18 and older with mild to moderate hearing loss. People with severe hearing loss and children still need prescriptions for the devices.

President Joe Biden had issued an executive order in 2021 directing the Health and Human Services Department and FDA to develop a rule allowing over-the-counter sales of hearing aids. The White House announced the availability of the hearing aids earlier Monday.

Some 30 million people in the U.S. have hearing loss but only about one-fifth of these individuals have hearing aids and use them, according to FDA. Many people who could benefit from the devices either can’t access them due to cost while other people don’t use them due to perceived stigma, according the agency.

The FDA, in analysis, estimated that over-the-counter hearing aids could save consumers about $1,438 because they are not bundled with costly professional services.

CNBC Health & Science

Read CNBC’s latest global health coverage:



Source

Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly
Health

Danish weight loss drug maker outlines ambitious 2030 strategy, ramping up pressure on Novo, Lilly

Celsopupo | Istock | Getty Images Zealand Pharma on Thursday outlined an ambitious five-year strategy for its anti-obesity portfolio Thursday, spotlighting how growing competition from smaller players is tightening the race for market leaders Novo Nordisk and Eli Lilly as more of these medicines near market entry. The new strategy, “Metabolic Frontier 2030,” comes as Zealand […]

Read More
Eli Lilly to build  billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs
Health

Eli Lilly to build $6 billion manufacturing plant in Alabama to help make upcoming obesity pill, other drugs

Eli Lilly CEO David A. Ricks speaks at a press conference at Generation Park in Houston, Monday, Sept. 23, 2025. The company announced plans for a $6.5 billion biomanufacturing plant in north Houston. (Raquel Natalicchio/Houston Chronicle via Getty Images) Raquel Natalicchio | Houston Chronicle | Getty Images Eli Lilly on Tuesday said it will spend […]

Read More
A biotech stock for investors scared to invest in the risky industry
Health

A biotech stock for investors scared to invest in the risky industry

Citigroup thinks investors should consider Ligand Pharmaceuticals for a more conservative bet on the biotech industry. The bank initiated the biotech stock at a buy rating and price target of $270, implying upside of 46% from Ligand’s Monday closing price of $184.67. Shares have soared nearly 79% this year. LGND YTD mountain LGND YTD chart […]

Read More